Status:

UNKNOWN

A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC

Lead Sponsor:

The Third Xiangya Hospital of Central South University

Conditions:

Pancreatic Ductal Adenocarcinoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The Aim of this study is to investigate the amount of tissue required for the successful culture of primary cells from human-derived pancreatic ductal adenocarcinoma which obtained by endoscopic ultra...

Detailed Description

Pancreatic cancer is one of the malignant tumors with the highest mortality rate in the world, with a 5-year survival rate of only 7.2%-9%. Because some patients are resistant to multiple chemotherapy...

Eligibility Criteria

Inclusion

  • Male or female, age≥18
  • Imaging examination (US, MRI, CT or PET-CT) of patients confirmed pancreatic lesions, and considered the possibility of PDAC, EUS-FNB was needed for auxiliary diagnosis
  • No chemotherapy, including neoadjuvant chemotherapy, postoperative adjuvant chemotherapy and palliative chemotherapy, has been performed on patients
  • Agree to attend this study and signed informed consent

Exclusion

  • Poor physical condition, including but not limited to hemoglobin ≤ 8.0g/dl, severe cardiopulmonary insufficiency, etc
  • Coagulation dysfunction (platelet count \< 50 × 1012, international standardized ratio \> 1.5), or inability to discontinue anticoagulation therapy
  • High risk for deep sedation
  • Acute pancreatitis in the previous 2 weeks
  • Pregnancy or lactation
  • Any diseases leading to unreliable follow-up
  • Absence of informed consent

Key Trial Info

Start Date :

January 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04794140

Start Date

January 15 2021

End Date

January 31 2022

Last Update

March 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Third Xiangya Hospital, Central South University,

Changsha, Hunan, China, 410013